Intrarectal application of amifostine for the prevention of radiation-induced rectal injury

Seminars in Radiation Oncology

Volumn 12, Issue 1 SUPPL. 1, 2002, Pages 81-85

  Ben Josef, Edgar ^a,b,c,d,e,f   Han, Sue ^a,b,c,d,e   Tobi, Martin ^a,b,c,d,e   Vargas, Barbara J ^a,b,c,d,e   Stamos, Beth ^a,b,c,d,e   Kelly, Laura ^a,b,c,d,e   Biggar, Sandra ^a,b,c,d,e   Kaplan, Irving ^a,b,c,d,e  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c John Dingell VA Medical Center   (United States)

^d Beth Israel Deaconess Medical Center Israel   (Israel)

^e HARVARD MEDICAL SCHOOL   (United States)

^f HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE;

CLINICAL ARTICLE; CLINICAL TRIAL; COLON DIVERTICULOSIS; COMPUTER ASSISTED RADIOTHERAPY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERABILITY; FOLLOW UP; HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; RECTUM INJURY; RECTUM POLYP; SIDE EFFECT; SYMPTOMATOLOGY; ULCERATIVE COLITIS;

EID: 0036126435     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2002.31379     Document Type: Conference Paper

References (17)

1. Status of prostate cancer at Stanford University
2. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706
3. Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: Experience at the Mallinckrodt Institute of Radiology
4. Improving the therapeutic ratio of external beam irradiation for carcinoma of the prostate
5. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer; Further evidence for a significant dose effect
6. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma
7. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial
8. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial
9. Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment and duration of morbidity
10. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone
11. Differential chemoprotection of normal and malignant tissues
12. Use of radiation with or without WR-2721 in advanced rectal cancer
13. Topical application of WR-2721 achieves high concentrations in the rectal wall
14. Late rectal bleeding following combined x-ray and proton high dose irradiation for patients with stages T3-T 4 prostate carcinoma
15. Conformal irradiation of the prostate: Estimating long-term rectal bleeding risk using dose-volume histograms
16. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms
17. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer